Pharma Reaserch Prod Co Ltd Cash Flow Quality Index
Pharma Reaserch Prod Co Ltd cash flow quality index. Pharma Reaserch Prod Co Ltd (214450) has a Cash Flow Quality Index of 1.89x as of December 2025. Operating cash flow of ₩61.53 Billion exceeds net income of ₩32.57 Billion, indicating high earnings quality where cash backs reported profits. See Pharma Reaserch Prod Co Ltd (214450) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Pharma Reaserch Prod Co Ltd (2015–2025)
Cash flow quality index of Pharma Reaserch Prod Co Ltd from 2015 to 2025. Historical Cash Flow Quality Index for Pharma Reaserch Prod Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 214450 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Pharma Reaserch Prod Co Ltd Cash Flow Quality Index by Year (2015–2025)
Pharma Reaserch Prod Co Ltd cash flow quality index by year from 2015 to 2025. Year-by-year earnings quality comparison for Pharma Reaserch Prod Co Ltd. For the full cash flow conversion analysis, see 214450 cash generation efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.11x | ₩183.16 Billion | ₩165.12 Billion | ▼ -29.4% |
| 2024 | 1.57x | ₩139.88 Billion | ₩89.01 Billion | ▲ +81.9% |
| 2023 | 0.86x | ₩64.95 Billion | ₩75.18 Billion | ▼ -40.3% |
| 2022 | 1.45x | ₩59.40 Billion | ₩41.04 Billion | ▲ +3.7% |
| 2021 | 1.40x | ₩65.30 Billion | ₩46.76 Billion | ▲ +41.3% |
| 2020 | 0.99x | ₩32.39 Billion | ₩32.77 Billion | ▼ -14.5% |
| 2019 | 1.16x | ₩19.27 Billion | ₩16.67 Billion | ▲ +220.2% |
| 2018 | 0.36x | ₩5.20 Billion | ₩14.41 Billion | ▼ -45.3% |
| 2017 | 0.66x | ₩8.56 Billion | ₩12.96 Billion | ▲ +11.9% |
| 2016 | 0.59x | ₩8.16 Billion | ₩13.83 Billion | ▼ -52.6% |
| 2015 | 1.24x | ₩16.02 Billion | ₩12.88 Billion | — |